Mindscape Collective is now The Consciousness Library. Same library, new name. You may need to sign in again. About the change
Skip to content

Gerard Dijkstra

2 papers in the library · 6 citations · publishing 2024-2025

Papers

Group-Delivered Mindfulness-Based Cognitive Therapy to Reduce Psychological Distress and Improve Sleep in Patients With Inflammatory Bowel Diseases: A Multicenter Randomized Controlled Trial (MindIBD).

Inflammatory bowel diseases July 14, 2025 Milou M Ter Avest, Marloes J. Huijbers, Carmen S Horjus et al. 6 citations

Mindfulness-Based Cognitive Therapy (MBCT) added to usual care reduces psychological distress and improves well-being in patients with inflammatory bowel disease (IBD) who are in remission but experiencing at least mild distress. In a randomized trial with 142 participants, those receiving group MBCT showed a moderate reduction in distress (effect size -0.61) and improved well-being (0.40) after the intervention, with effects strengthening over time. Objective sleep measures indicated less total sleep time but a higher proportion of deep sleep. Although flare rates did not differ, fecal calprotectin levels, a marker of gut inflammation, decreased in the MBCT group over the follow-up period (effect size -0.49). MBCT may benefit both psychological and biological aspects of IBD.

DOI: 10.1093/ibd/izaf116 (opens in new tab) Full text (opens in new tab) Mbct Mindfulness-based cognitive therapy Inflammatory bowel diseases Psychological distress +18

Long-term treatment outcomes of mindfulness-based cognitive therapy for fatigue in patients with inflammatory bowel disease: Results of a randomized controlled trial.

Journal of Psychosomatic Research December 1, 2024 Quirine M Bredero, Joke Fleer, Ans Smink et al.

Fatigue is common among people with inflammatory bowel disease (IBD) in remission. A randomized controlled trial tested whether fatigue reductions from mindfulness-based cognitive therapy (MBCT) lasted nine months. Among 108 fatigued IBD patients who received MBCT, the reduced fatigue level post-treatment did not change significantly during follow-up. 29% of patients reported clinically relevant improvement from before treatment to nine months. Secondary outcomes (fatigue interference, depression, anxiety, quality of life) remained stable. Patients who improved were significantly more often unemployed. The findings suggest that MBCT's fatigue reductions are sustained over nine months, with about one-third of patients experiencing clinically meaningful improvement.

DOI: 10.1016/j.jpsychores.2024.111949 (opens in new tab) Full text (opens in new tab) Fatigue Inflammatory bowel disease Long-term effects Mindfulness-based cognitive therapy +1